E trade-offs with regards to costs and performance in people living with HIV. The cost-effectiveness of novel diagnostic algorithms that incorporate these new tools alone or in combination with each other and with conventional diagnostic modalities is unknown. Prior studies have suggested that Xpert replacement of smear-microscopy is cost-effective for diagnosis of pulmonary TB in the general popu